期刊文献+

肾移植受者活动性CMV感染的发生状况 被引量:1

Active cytomegalovirus infection after renal transplantation
下载PDF
导出
摘要 目的 明确肾移植患者术前CMV感染的发生率和术后活动性CMV感染的发生规律。方法 检测27例健 康成人、以及我院2002年3月至2003年6月138例尿毒症患者肾移植前血清抗CMV抗体(抗CMV IgG、CMV IgM);观察肾 移植后CMV pp65抗原血症的动态变化。结果 27例健康成人血清抗CMV IgM均为阴性、抗CMV IgG的阳性率为70.4%、 外周血CMV pp65(+)白细胞数为0~4个/5×104WBC;尿毒症患者术前CMV IgG、CMV IgM阳性率分别为93.5%、7.1%, 肾移植后外周血CMV pp65(+)白细胞数为0~2280个/5×104WBC(其中>5者占87.0%)、其高峰期在术后第6~8周。 结论 肾移植受者术前CMV感染发生率明显高于健康人群,且至少有7.1%存在着活动性CMV感染;肾移植患者术后6 个月内,活动性CMV感染发生率高达86.96%;术后第6~8周是活动性CMV感染最严重的时期。 Objective To investigate the incidence of active cytomegalovirus (CMV) infection before renal transplantation, and the regularity of active CMV infection after renal transplantation. Methods Serum antibodies of CMV-IgG and CMV-IgM were detected in 27 healthy subjects, employed as control group, and in 138 uremia patients before renal transplantation. The variation in number of pp65 positive cells in peripheral blood of patients after renal transplantation was determined. Results Serum antibodies of CMV-IgM were all negative, and the rate of CMV-IgG positive was 70.4%, and the number of pp65 positive cells in peripheral blood was 0-4 cells in 5×10 4 WBCs. The positive rates of CMV-IgG and CMV-IgM were 93.5% and 7.1% respectively, and the number of pp65 positive cells in peripheral blood was 0-2 280 cells in 5×10 4 WBCs in patients after renal transplantation. The peak time of the number of pp65 positive cells in peripheral blood was in the period from 6 to 8 weeks after renal transplantation. Conclusion The incidence of active CMV infection before renal transplantation is at least 7.1%, which is higher than that in control group. Incidence of active CMV infection is 87.0% in the first 6 months after renal transplantation. Active CMV infection is the most serious in the period from 6 to 8 weeks after renal transplantation.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2005年第5期425-428,共4页 Journal of Third Military Medical University
关键词 肾移植 巨细胞病毒 Kidney transplantation cytomegalovirus
  • 相关文献

参考文献13

  • 1Yeung J S, Tong K L, Chan H W, et al. Clinical pattern, risk factors,and outcome of CMV infection in renal transplant recipients: local experience[J]. Transplant Proc, 1998, 30(7): 3144- 3145.
  • 2Poirier Toulemonde A S, Milpied N, Cantarovich D, et al. Clinical relevance of direct quantification of pp65 antigenemia using flow cytometry in solid organ and stem cell transplant recipients[J]. J Clin Microbiol, 2000,38(9): 3143 - 3149.
  • 3Lee W, Tsang W K, Tong K L, et al. Cytomegalovirus infection and graft rejection in renal transplantation: a single-center experience[J]. Transplant Proc, 2003, 35(1): 282-283.
  • 4Inkinen K, Soots A, Krogerus L, et al. Cytomegalovirus increases collagen synthesis in chronic rejection in the rat[J]. Nephrol Dial Transplant, 2002,17(5): 772 - 779.
  • 5Pirsch J D. Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U. S. multicenter FK506 Kidney Transplant Study Group[J]. Transplantation, 1999, 68(8):1203- 1205.
  • 6Van-der-Bij W, Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation [ J ]. Clin Infect Dis, 2001, 33(Suppl 1): S32 - S37.
  • 7Paggs K S, Mackinnon S. Cytomegalovirus: the role of CMV post-haematopoietic stem cell transplantation[J]. Int J Biochem Cell Biol, 2004, 36(4): 695 - 701.
  • 8Paul L C. Chronic allograft nephropathy: an update[J]. Kidney Int, 1999,56(3): 783 - 793.
  • 9Vazquez M A. Chronic rejection of renal transplants: new clinical insights[J]. Am J Med Sci, 2000, 320(1): 43-58.
  • 10Kloover J S, Soots A P, Krogerus L A, et al. Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft[J]. Transplantation, 2000, 69(12): 2641-2647.

同被引文献15

  • 1林孝怡,季育华.人巨细胞病毒pp65蛋白的研究进展[J].临床输血与检验,2006,8(1):74-75. 被引量:11
  • 2杨美芳,高海女,范骏,陈晓明,薛寒,马伟杭.pp65抗原血症监测异基因造血干细胞移植受体CMV的感染[J].中华微生物学和免疫学杂志,2006,26(11):993-993. 被引量:6
  • 3李薇,谢闻悦,陈永强,刘俊,张璇.应用间接免疫荧光技术检测人巨细胞病毒-PP65抗原的临床意义[J].实用医学杂志,2007,23(9):1398-1400. 被引量:13
  • 4Gilbert C,Boivin G.Human comegalovims resistance to antiviral drugs.Antimicrob Agents Chemother 2005;49:873.
  • 5Preiser W, Brauninger S, Schwerdtfeger R,et al. Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transolants.J Clin Virol 2001;20(1-2):59-70.
  • 6Reisch T, Jindra P, Mares J,et al.The human for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection. Transplantation 2005;79(3):317.
  • 7Ktaus H,Mathias P, Hans-Eberhard S,et al.Human cytomegalovims infection of a severe-burn patient:Evidence for productive selflimited viral replication in blood and lung.J Clin Microbiol 2005;43(5):2534.
  • 8Carlo M,Jccardo C,Matin A B,et al. Assessmem of CMV load in solid organ transplant recipient by pp65 antigenmia and real-time quantitative DNA PCR assay correlation witll pp67 RNA detection.J Med Virol 2004;74(1):78-84.
  • 9Diaz-Mitoma F, Leger C,Miller H,et al.Comparison of DNA amplification, mRNA amplification,and DNA hybridization techniques for detection of cytomegalovirus in bone marrow transplantrecipients.J C4in Microbiol 2003;41(11):5159-5166.
  • 10Zhang F, Tetali S,Wang XP, et al. Detection of human cytomegalovirus pp67 late gene transcripts in cerebrospinal fluid of human immunodeficiency virus type 1-infected patients by nucleic acid sequence-based amplification.J Clin Microbiol 2000;8(5):1920-1925.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部